Developments Santhera inks exclusive distribution deal with Clinigen for AGAMREE in DMD Santhera Pharmaceuticals (SIX:SANN) and closely held Clinigen Group have announced the signing of a supply and distribution agreement that will make AGAMREE accessible to patients with Duchene muscular dystrophy (DMD)... January 6, 2025